Cell & Gene Therapy World Asia 2027

As the region emerges as a global leader in regenerative medicine, Cell & Gene Therapy World Asia 2027 (#CGTAsia2027) returns as Asia’s most anticipated CGT knowledge-sharing conference for the 11th year! Designed to connect and empower stakeholders from the cell and gene therapy ecosystem, the event provides an unparalleled platform to explore the latest advancements in cell therapies, gene therapies, and CAR-T technologies.

Hear from 50+ leading industry experts across Singapore, China, Japan, South Korea, Taiwan, and Australia as they share the latest advancements and future directions in cell and gene therapy, spanning CAR-T, TCR-T, gene editing, viral vectors, and next-generation CGT manufacturing platforms.

Engage with 500+ senior-level decision-makers across biopharma, big pharma, CDMOs, academia, and technology providers to gain forward-looking insights into CGT development, clinical translation, manufacturing scale-up, and commercialization strategies in Asia. 

Participate in a dedicated Poster Presentation Session showcasing cutting-edge CGT research, translational science, vector engineering, and early-stage innovations from leading academic institutes, biotech startups, and clinical research teams across Asia.

The region continues to be a global leader in gene and cell therapy with a compound annual growth rate surpassing 40%. Factors driving this growth include:

Rising Prevalence of Chronic Diseases: Growing demand for advanced therapeutics.